(IHF) iShares U.S. Healthcare - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US4642888287 • Health

IHF: Health, Providers, Services, Insurance, Hospitals, Pharmaceuticals

The iShares U.S. Healthcare Providers ETF (IHF) is designed to track the performance of companies within the healthcare providers sector in the U.S. equity market. This sector encompasses a range of businesses, including hospitals, health insurance providers, and medical services firms. The fund typically invests at least 80% of its assets in securities that are part of its underlying index or in investments that closely mirror these securities. This approach allows the fund to maintain a close alignment with the indexs performance. Additionally, up to 20% of its assets may be allocated to derivatives, such as futures and options, as well as cash and cash equivalents, providing flexibility in managing the portfolio. It is important to note that IHF is classified as a non-diversified fund, which means it may concentrate its holdings in a smaller number of securities, potentially leading to higher volatility compared to diversified funds. For more information, please visit the iShares website at http://www.ishares.com.

As of the latest available data, the iShares U.S. Healthcare Providers ETF (IHF) manages approximately $662.40 million in assets. This ETF is listed on the NYSE ARCA under the ticker symbol IHF and falls under the Health category. The funds focus on the healthcare providers sector makes it a targeted investment option for those looking to gain exposure to this specific area within the healthcare industry.

Looking ahead, the future outlook for the healthcare providers sector, as reflected by the iShares U.S. Healthcare Providers ETF (IHF), is influenced by several key factors. From a demographic perspective, the aging population in the U.S. is expected to drive increased demand for healthcare services, which could benefit companies in this sector. Additionally, ongoing developments in healthcare policy and regulation, such as potential reforms or changes in reimbursement models, could have significant implications for the sector. Technological advancements, particularly in areas like telemedicine and digital health platforms, may also play a role in shaping the future landscape of healthcare providers. Furthermore, the financial health of the sector will be closely tied to factors such as revenue growth, cost management, and valuations. As with any investment, it is important to consider these dynamics and how they may impact the performance of the ETF over time.

Additional Sources for IHF ETF

IHF ETF Overview

Market Cap in USD 654m
Category Health
TER 0.40%
IPO / Inception 2006-05-01

IHF ETF Ratings

Growth Rating 31.4
Fundamental -
Dividend Rating 42.4
Rel. Strength 0.07
Analysts -
Fair Price Momentum 51.52 USD
Fair Price DCF -

IHF Dividends

Dividend Yield 12m 0.77%
Yield on Cost 5y 1.15%
Annual Growth 5y 10.45%
Payout Consistency 61.2%

IHF Growth Ratios

Growth Correlation 3m 32.4%
Growth Correlation 12m -19.1%
Growth Correlation 5y 50.1%
CAGR 5y 8.31%
CAGR/Max DD 5y 0.44
Sharpe Ratio 12m 0.55
Alpha 0.17
Beta 0.710
Volatility 21.63%
Current Volume 94.4k
Average Volume 20d 97.2k
What is the price of IHF stocks?
As of April 16, 2025, the stock is trading at USD 54.14 with a total of 94,434 shares traded.
Over the past week, the price has changed by +3.90%, over one month by +4.19%, over three months by +7.39% and over the past year by +8.00%.
Is iShares U.S. Healthcare a good stock to buy?
Neither. Based on ValueRay Analyses, iShares U.S. Healthcare is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 31.43 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IHF as of April 2025 is 51.52. This means that IHF is currently overvalued and has a potential downside of -4.84%.
Is IHF a buy, sell or hold?
iShares U.S. Healthcare has no consensus analysts rating.
What are the forecast for IHF stock price target?
According to ValueRays Forecast Model, IHF iShares U.S. Healthcare will be worth about 56.7 in April 2026. The stock is currently trading at 54.14. This means that the stock has a potential upside of +4.73%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 56.7 4.7%